New antibody shows promise against dangerous staph blood infections
NCT ID NCT02357966
First seen Feb 28, 2026 · Last updated May 10, 2026 · Updated 9 times
Summary
This study tested a new human antibody called 514G3 in 52 hospitalized patients with Staphylococcus aureus bloodstream infections. Participants received either a single dose of the antibody plus standard antibiotics or a placebo plus antibiotics. The goal was to check safety and find the best dose. The antibody aims to help the immune system fight the infection faster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BACTEREMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
XBiotech Investigative Site
Columbus, Georgia, 31904, United States
-
XBiotech Investigative Site
Charlotte, North Carolina, 28203, United States
Conditions
Explore the condition pages connected to this study.